NATCO PHARMA LTD. - 524816 - Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended 31St March, 2024

Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Strong Performer, Under Radar

862.2000 13.95 (1.64%)

NSE Sep 12, 2025 15:31 PM

45.91% Fall from 52W High

Volume: 287.6K

Natco Pharma Ltd.

27 May 2024

862.20

1.64%

Board Meeting

NATCO PHARMA LTD. - 524816 - Board Meeting Outcome for Audited Financial Results For The Quarter …

BSE India

Audited Financial Results for the quarter and year ended 31st March, 2024

More from Natco Pharma Ltd.

All earning calls

Investor presentations from Natco Pharma Ltd.

All investor presentations